Blog - Page 6 of 11 - Frier Levitt Government Affairs

Health Policy Check Up News
Our blog provides timely insight on the latest industry trends. We discuss manufacturing, acute and post-acute care issues.
Stay current with our latest insights.
Δ

February 1, 2019

Take Action: New CMS Proposed Rule Targeting Manufacturers, Patient Assistance Programs, ACOs, Payers and ACA Exchange Stakeholders

January 23, 2019

CMS Permits Use of Step Therapy for Part B Drugs with Medicare Advantage Plans Affecting Physician Dispensing and Specialty Pharmacy Patients

January 16, 2019

Modifying HIPAA Rules: OCR Looks for Input from Physicians, Hospitals and Healthcare Stakeholders

January 14, 2019

Growing Trend Toward PBM Transparency Provides Opportunities for State Medicaid Directors

January 10, 2019

Take Action: Pharmacy Industry Asked to Comment on the New CMS Proposed Rule Aimed at DIR Fees

December 20, 2018

State and Pharmacy Associations Can Demand Greater Conditions of Approval from Agencies that Oversee PBM and Insurer Mergers

December 14, 2018

What You Need to Know: The HHS “Reforming America’s Healthcare System Through Choice and Competition” Report

November 19, 2018

Last Opportunity to Comment on New CMS Final Rule That Will Negatively Impact Home Infusion Reimbursement

November 12, 2018

CMS IPI Blog Post

New CMS Payment Model Will Impact Hospitals, Manufacturers, and Infusion and Oncology Providers

November 2, 2018

The Current State of U.S. Biosimilar Policies – An Overview